Wednesday, May 2, 2018

Accounting concerns wipe $6bn off Samsung BioLogics market value

The change to fair value, and the subsequent net profit, was approved by KPMG Korea, Deloitte Korea and PricewaterhouseCoopers Korea, and the FSS did not raise an issue when it released the 2015 books in 2016, the company added. An FSS official declined to comment. Shares in Samsung C&T ...
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates